Table 2.

Dosing Regimens of Antibiotics

Study	Antibiotic	Dose	Frequency, % of (n)
Kutob (most common regimens reported)	Amoxicillin/clavulanic acid (n = 30)	875/125 mg q12h	70
		500/125 mg q8h	30
	Amoxicillin (n = 12)	500 mg q8h	83
	Cephalexin (n = 16)	500 mg q6h	56
	Levofloxacin (n = 106)	500 mg q24h	48
		750 mg q24h	33
	Ciprofloxacin (n = 151)	500 mg q12h	84
	TMP-SMX (n = 28)	800/160 mg q12h	100
Mercuro (doses for normal renal function only)	Amoxicillin/clavulanic acid (n = 25)	875/125 mg q12h	92
		500/125 mg q12h	4
		500/125 mg q8h	4
	Amoxicillin (n = 8)	1000 mg q8h	50
		500 mg q8h	37.5
		500 mg q12h	12.5
	Cephalexin (n = 11)	500 mg q6h	82
		500 mg q8h	9
		500 mg q12h	9
	Levofloxacin (n = 29)	500 mg q24h	13.7
		750 mg q24h	82.7
	Ciprofloxacin (n = 56)	500 mg q12h	91
		750 mg q12h	7.1
Tamma	Amoxicillin/clavulanic acid (n = 38)	500–1000 mg q 8–12h	N.A.
	Cephalexin (n = 16)	500 mg q 6h	N.A.
	Cefpodoxime (n = 17)	200–400 mg q12h	N.A.
	Ciprofloxacin (n = 337)	500–750 mg q12h	N.A.
	Levofloxacin (n = 171)	500–750 mg q24h	N.A.
	Moxifloxacin (n = 10)	400 mg q24h	N.A.
	TMP-SMX (n = 99)	160–320 mg q6–12h	N.A.
Sessa	Subtherapeutic dosing:	No. (%)
	FQ/TMP-SMX	2/57 (3.51)
	ß-lactams	45/151 (29.8)

Abbreviations: FQ, fluoroquinolone; TMP-SMX, trimethoprim-sulfamethoxazole.